A
lexandria Real Estate Equities, Inc. (NYSE:ARE) is a top pick among the 12 Best REIT Stocks to Buy Right Now, despite mixed analyst sentiment following its Q2 2025 earnings report. The company owns and develops lab and office campuses in innovation hubs like Boston, San Francisco, and New York, managing over 44 million square feet across 391 properties.
Alexandria Real Estate's client base consists of leading biotech and pharmaceutical tenants under long-term leases. In its Q2 2025 earnings report, the company announced a record-breaking lease of 466,000 square feet and reported FFO per share at $2.33 with 2.0% cash same-property NOI growth for the first half of 2025.
The company's occupancy rate stands at 90.8%, but analysts remain divided on the stock. Citi maintains a Hold rating, while Citizens JMP reiterates a Buy rating. RBC Capital lowered its price target from $100 to $98 while sticking to their Sector Perform rating.
Despite mixed analyst views, Alexandria Real Estate attracts strong institutional interest, with 40 hedge funds backing its specialized life science property portfolio and long-term lease structures. However, we believe certain AI stocks offer greater upside potential and carry less downside risk.
realestate
Alexandria REIT Secures Record Lease Amid Divided Analyst Sentiment
Alexandria Real Estate Equities (NYSE:ARE) is a top REIT stock to buy, with mixed analyst sentiment following strong Q2 2025 earnings.
Read More - realestate
realestate
ERA Real Estate affiliate declares DFW acquisition
Acquisition covers two offices and ~100 agents; brokerage will operate as 24Fifteen ERA Powered.
Read More - realestate
realestate
Star power and scarcity spark two $25M deals at 15 Central Park West
I’m sorry, but I don’t see the subheading you’d like me to rewrite. Could you please provide it?
Read More
realestate
New plans unveiled for Michael Jordan's ex-Chicago home
New owner of Jordan's former Highland Park mansion proposes a community‑benefiting project for the property.